| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal glucose metabolism among older men with or at risk of HIV infection
|
Howard, AA
|
|
2006
|
|
6 |
p. 389-396
|
artikel
|
| 2 |
Adverse events experienced by three children taking tenofovir and didanosine in combination
|
Hawkins, S
|
|
2007
|
|
6 |
p. 411
|
artikel
|
| 3 |
A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophy
|
Bickel, M
|
|
2006
|
|
6 |
p. 397-403
|
artikel
|
| 4 |
Aweeka FT, Kang M, Yu J-Y, Lizak P, Aston B, Chung RT. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team. HIV Med 2007; 8: 288–294
|
|
|
2007
|
|
6 |
p. 412
|
artikel
|
| 5 |
CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/μL
|
Moore, DM
|
|
2006
|
|
6 |
p. 383-388
|
artikel
|
| 6 |
Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic
|
Skiest, D
|
|
2006
|
|
6 |
p. 361-368
|
artikel
|
| 7 |
Effects of age and sex on immunological and virological responses to initial highly active antiretroviral therapy
|
Patterson, K
|
|
2007
|
|
6 |
p. 406-410
|
artikel
|
| 8 |
Evaluation of the use of dried spots and of different storage conditions of plasma for HIV-1 RNA quantification
|
Amellal, B
|
|
2007
|
|
6 |
p. 396-400
|
artikel
|
| 9 |
Ferritin levels during structured treatment interruption of highly active antiretroviral therapy
|
Boom, J
|
|
2007
|
|
6 |
p. 388-395
|
artikel
|
| 10 |
Fulminant toxoplasmosis causing fatal pneumonitis and myocarditis
|
Eza, DE
|
|
2006
|
|
6 |
p. 415-420
|
artikel
|
| 11 |
HIV forensics: pitfalls and acceptable standards in the use of phylogenetic analysis as evidence in criminal investigations of HIV transmission *
|
Bernard, EJ
|
|
2007
|
|
6 |
p. 382-387
|
artikel
|
| 12 |
Incidence and risk factors of rash associated with efavirenz in HIV-infected patients with preceding nevirapine-associated rash
|
Manosuthi, W
|
|
2006
|
|
6 |
p. 378-382
|
artikel
|
| 13 |
Influence of a monocyte chemoattractant protein 1 mutated allele on the response to protease inhibitor-based antiretroviral therapy
|
Coll, B
|
|
2006
|
|
6 |
p. 356-360
|
artikel
|
| 14 |
Interactions between protease inhibitors and acid-reducing agents: a systematic review
|
Béïque, L
|
|
2007
|
|
6 |
p. 335-345
|
artikel
|
| 15 |
Lymphoid pneumonitis as an immune reconstitution inflammatory syndrome in a patient with CD4 cell recovery after HAART initiation
|
Ingiliz, P
|
|
2006
|
|
6 |
p. 411-414
|
artikel
|
| 16 |
Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women
|
Phanuphak, N
|
|
2007
|
|
6 |
p. 357-366
|
artikel
|
| 17 |
Plasma lipid concentrations after 1.5 years of exposure to nevirapine or efavirenz together with stavudine and lamivudine
|
van Leth, F
|
|
2006
|
|
6 |
p. 347-350
|
artikel
|
| 18 |
Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993–2006
|
Smyth, K
|
|
2007
|
|
6 |
p. 367-373
|
artikel
|
| 19 |
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study
|
Glass, TR
|
|
2006
|
|
6 |
p. 404-410
|
artikel
|
| 20 |
Race and ethnicity impact on the maximum proliferative response in peripheral blood lymphocytes from HIV-seropositive individuals
|
Kolber, MA
|
|
2007
|
|
6 |
p. 401-405
|
artikel
|
| 21 |
The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta
|
Gingues, S
|
|
2006
|
|
6 |
p. 369-377
|
artikel
|
| 22 |
The management of dyslipidaemias in antiretroviral-treated HIV infection: a systematic review
|
McGoldrick, C
|
|
2007
|
|
6 |
p. 325-334
|
artikel
|
| 23 |
The public health impact of widespread availability of nonoccupational postexposure prophylaxis against HIV
|
Poynten, IM
|
|
2007
|
|
6 |
p. 374-381
|
artikel
|
| 24 |
The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients
|
Olawumi, HO
|
|
2006
|
|
6 |
p. 351-355
|
artikel
|
| 25 |
Use of metabolic drugs and fish oil in HIV-positive patients with metabolic complications and associations with dyslipidaemia and treatment targets
|
Normén, L
|
|
2007
|
|
6 |
p. 346-356
|
artikel
|
Tijdschrift beschrijving